Total Payments
$54,629
2024 Payments
$4,254
Companies
93
Transactions
1,213
Medicare Patients
6,802
Medicare Billing
$954,212
Payment Breakdown by Category
Food & Beverage$26,532 (48.6%)
Consulting$18,760 (34.3%)
Other$6,616 (12.1%)
Travel$2,155 (3.9%)
Education$566.02 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,532 | 1,170 | 48.6% |
| Consulting Fee | $18,760 | 10 | 34.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,918 | 2 | 5.3% |
| Honoraria | $2,700 | 2 | 4.9% |
| Travel and Lodging | $2,155 | 7 | 3.9% |
| Long term medical supply or device loan | $998.48 | 11 | 1.8% |
| Education | $566.02 | 11 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $9,579 | 71 | $0 (2024) |
| ABBVIE INC. | $6,051 | 37 | $0 (2024) |
| Heron Therapeutics, Inc. | $5,460 | 20 | $0 (2020) |
| Secura Bio, Inc. | $3,122 | 8 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $3,003 | 116 | $0 (2024) |
| GENZYME CORPORATION | $2,223 | 19 | $0 (2024) |
| Seattle Genetics, Inc. | $1,524 | 3 | $0 (2019) |
| Fresenius Kabi USA, LLC | $1,500 | 1 | $0 (2021) |
| Genmab U.S., Inc. | $1,468 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $1,337 | 76 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,254 | 163 | Novartis Pharmaceuticals Corporation ($432.40) |
| 2023 | $6,279 | 200 | Genmab U.S., Inc. ($1,445) |
| 2022 | $4,135 | 184 | Novartis Pharmaceuticals Corporation ($779.60) |
| 2021 | $4,927 | 155 | Fresenius Kabi USA, LLC ($1,500) |
| 2020 | $1,227 | 67 | Janssen Biotech, Inc. ($139.39) |
| 2019 | $15,603 | 156 | Genentech USA, Inc. ($4,519) |
| 2018 | $8,203 | 145 | AbbVie, Inc. ($5,443) |
| 2017 | $10,002 | 143 | Genentech USA, Inc. ($4,424) |
All Payment Transactions
1,213 individual payment records from CMS Open Payments — Page 1 of 49
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Oncology | ||||||
| 12/17/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/04/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Education | In-kind items and services | $85.00 | General |
| Category: Rare Disease | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: HEMATOLOGY | ||||||
| 11/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Rare Disease | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Oncology | ||||||
| 11/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Spectrum Pharmaceuticals Inc. | ROLVEDON (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: BioOncology | ||||||
| 11/07/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Genentech USA, Inc. | Alecensa (Biological), Tecentriq, Tecentriq Hybreza | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: BioOncology | ||||||
| 10/31/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $28.24 | General |
| Category: Hematology/Oncology | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Oncology | ||||||
| 10/11/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 1,833 | 17,930 | $638,130 | $217,635 |
| 2022 | 34 | 1,543 | 30,954 | $615,320 | $219,221 |
| 2021 | 36 | 1,816 | 32,744 | $765,278 | $300,948 |
| 2020 | 28 | 1,610 | 12,149 | $519,367 | $216,407 |
Total Patients
6,802
Total Services
93,777
Medicare Billing
$954,212
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 34 | 3,601 | $144,000 | $66,262 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 210 | 489 | $58,680 | $30,162 | 51.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 143 | 617 | $49,360 | $26,306 | 53.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 208 | $33,280 | $17,709 | 53.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 41 | 132 | $46,200 | $11,943 | 25.9% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 39 | 50 | $50,000 | $7,852 | 15.7% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 15 | 1,218 | $36,000 | $7,067 | 19.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 297 | 924 | $27,690 | $6,927 | 25.0% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 13 | 345 | $43,125 | $5,692 | 13.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 232 | 623 | $6,220 | $5,080 | 81.7% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 12 | 89 | $9,790 | $4,459 | 45.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $6,380 | $3,227 | 50.6% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 21 | 69 | $11,730 | $3,131 | 26.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 76 | 255 | $12,750 | $2,593 | 20.3% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 36 | 236 | $14,160 | $2,549 | 18.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 42 | 42 | $6,300 | $2,451 | 38.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 25 | 56 | $14,000 | $2,392 | 17.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 36 | 49 | $29,400 | $1,967 | 6.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,640 | $1,218 | 46.1% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 13 | 62 | $4,960 | $1,211 | 24.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 28 | $2,800 | $1,144 | 40.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 23 | 55 | $4,950 | $1,111 | 22.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 16 | $1,600 | $1,049 | 65.6% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2023 | 13 | 15 | $3,000 | $780.00 | 26.0% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 17 | 17 | $1,700 | $760.92 | 44.8% |
About Dr. Asutosh Gor, MD
Dr. Asutosh Gor, MD is a Hematology & Oncology healthcare provider based in Rock Hill, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407947757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Asutosh Gor, MD has received a total of $54,629 in payments from pharmaceutical and medical device companies, with $4,254 received in 2024. These payments were reported across 1,213 transactions from 93 companies. The most common payment nature is "Food and Beverage" ($26,532).
As a Medicare-enrolled provider, Gor has provided services to 6,802 Medicare beneficiaries, totaling 93,777 services with total Medicare billing of $954,212. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Rock Hill, SC
- Active Since 09/28/2006
- Last Updated 10/22/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1407947757
Products in Payments
- Perjeta (Biological) $4,488
- TECENTRIQ (Biological) $4,285
- SUSTOL (Drug) $3,772
- FARYDAK (Drug) $3,038
- CD38 (Drug) $1,840
- CINVANTI (Drug) $1,689
- Epkinly (Drug) $1,468
- KISQALI (Drug) $1,324
- KEYTRUDA (Biological) $1,189
- OPDIVO (Biological) $764.88
- Lonsurf (Drug) $606.13
- IMBRUVICA (Drug) $570.60
- JAKAFI (Drug) $535.99
- LONSURF (Drug) $470.65
- DARZALEX (Biological) $420.81
- MONOFERRIC (Drug) $409.57
- LIBTAYO (Biological) $365.44
- VERZENIO (Drug) $355.63
- Cabometyx (Drug) $325.79
- INJECTAFER (Drug) $322.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.